Metrics to compare | 237690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship237690PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.4x | 9.9x | −0.3x | |
PEG Ratio | 0.26 | 0.09 | 0.00 | |
Price/Book | 3.7x | 0.9x | 2.6x | |
Price / LTM Sales | 6.5x | 0.7x | 3.1x | |
Upside (Analyst Target) | 77.6% | 52.5% | 48.3% | |
Fair Value Upside | Unlock | 19.0% | 6.7% | Unlock |
ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.